Author: | Drilon, A. |
Article Title: | MET exon 14 alterations in lung cancer: Exon skipping extends half-life |
Abstract: | MET exon 14 alterations are a diverse group of mutations, many of which disrupt splice acceptor or donor sites leading to exon 14 skipping, impaired receptor degradation, and oncogenic transformation. These alterations are clinically targetable with MET-directed therapy. ©2016 AACR. |
Journal Title: | Clinical Cancer Research |
Volume: | 22 |
Issue: | 12 |
ISSN: | 1078-0432 |
Publisher: | American Association for Cancer Research |
Date Published: | 2016-06-15 |
Start Page: | 2832 |
End Page: | 2834 |
Language: | English |
DOI: | 10.1158/1078-0432.ccr-16-0229 |
PROVIDER: | scopus |
PMCID: | PMC4911276 |
PUBMED: | 27009743 |
DOI/URL: | |
Notes: | Article -- Export Date: 1 July 2016 -- Source: Scopus |